Ardsley Advisory Partners Position in Therapeuticsmd (TXMD) Has Upped by $6.15 Million; Nxp Semiconductors N V (Call) (NXPI) Share Value Rose While Angelo Gordon & Company LP Boosted Its Position

May 18, 2018 - By wolcottdaily

NXP Semiconductors N.V. (NASDAQ:NXPI) Logo

Philip Hempleman increased its stake in Therapeuticsmd Inc (TXMD) by 4100% based on its latest 2017Q4 regulatory filing with the SEC. Ardsley Advisory Partners bought 1.03M shares as the company’s stock declined 18.84% with the market. The hedge fund run by Philip Hempleman held 1.05 million shares of the health care company at the end of 2017Q4, valued at $6.34 million, up from 25,000 at the end of the previous reported quarter. Ardsley Advisory Partners who had been investing in Therapeuticsmd Inc for a number of months, seems to be bullish on the $1.36B market cap company. The stock increased 2.62% or $0.1601 during the last trading session, reaching $6.2601. About 1.29M shares traded. TherapeuticsMD, Inc. (NYSEMKT:TXMD) has declined 30.29% since May 18, 2017 and is downtrending. It has underperformed by 41.84% the S&P500.

John M. Angelo increased its stake in Nxp Semiconductors N V (Call) (NXPI) by 170% based on its latest 2017Q4 regulatory filing with the SEC. Angelo Gordon & Company Lp bought 170,000 shares as the company’s stock rose 4.13% while stock markets declined. The hedge fund run by John M. Angelo held 270,000 shares of the semiconductors company at the end of 2017Q4, valued at $31.61 million, up from 100,000 at the end of the previous reported quarter. Angelo Gordon & Company Lp who had been investing in Nxp Semiconductors N V (Call) for a number of months, seems to be bullish on the $38.19 billion market cap company. The stock increased 4.04% or $4.31 during the last trading session, reaching $111.02. About 7.54M shares traded or 13.20% up from the average. NXP Semiconductors N.V. (NASDAQ:NXPI) has risen 17.73% since May 18, 2017 and is uptrending. It has outperformed by 6.18% the S&P500.

Among 28 analysts covering NXP Semiconductors NV (NASDAQ:NXPI), 10 have Buy rating, 1 Sell and 17 Hold. Therefore 36% are positive. NXP Semiconductors NV had 72 analyst reports since August 3, 2015 according to SRatingsIntel. Canaccord Genuity maintained the shares of NXPI in report on Friday, August 25 with “Hold” rating. The stock of NXP Semiconductors N.V. (NASDAQ:NXPI) earned “Sector Weight” rating by Pacific Crest on Tuesday, November 1. As per Thursday, October 27, the company rating was downgraded by Jefferies. The firm has “Hold” rating given on Friday, October 28 by Suntrust Robinson. The firm earned “Neutral” rating on Thursday, November 3 by Mizuho. Summit Redstone Partners initiated NXP Semiconductors N.V. (NASDAQ:NXPI) on Wednesday, July 20 with “Buy” rating. BMO Capital Markets maintained the stock with “Outperform” rating in Friday, October 30 report. Jefferies maintained NXP Semiconductors N.V. (NASDAQ:NXPI) on Thursday, October 26 with “Hold” rating. Raymond James downgraded the shares of NXPI in report on Tuesday, April 19 to “Outperform” rating. The stock has “Hold” rating by Oppenheimer on Thursday, October 26.

More notable recent NXP Semiconductors N.V. (NASDAQ:NXPI) news were published by: Globenewswire.com which released: “NXP Semiconductors Reports First Quarter 2018 Results” on May 03, 2018, also Streetinsider.com with their article: “Beijing Official Says NXP Semiconductors (NXPI), Qualcomm (QCOM) Looking More Optimistic – DJ” published on May 18, 2018, Seekingalpha.com published: “China restarts Qualcomm-NXP deal review” on May 14, 2018. More interesting news about NXP Semiconductors N.V. (NASDAQ:NXPI) were released by: Nasdaq.com and their article: “China Eases the Pressure on Qualcomm’s NXP Deal” published on May 15, 2018 as well as Seekingalpha.com‘s news article titled: “NXP Semiconductors -4% on Q1 revenue miss” with publication date: May 03, 2018.

Ardsley Advisory Partners, which manages about $862.45M and $823.02M US Long portfolio, decreased its stake in Progenics Pharmaceuticals In (NASDAQ:PGNX) by 80,000 shares to 1.83 million shares, valued at $10.89 million in 2017Q4, according to the filing. It also reduced its holding in Proshares Tr (TBT) by 1.54 million shares in the quarter, leaving it with 65,000 shares, and cut its stake in Amicus Therapeutics Inc (NASDAQ:FOLD).

Among 4 analysts covering TherapeuticsMD (NYSEMKT:TXMD), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. TherapeuticsMD had 6 analyst reports since September 21, 2015 according to SRatingsIntel. The company was reinitiated on Tuesday, November 22 by Jefferies. The stock has “Buy” rating by Jefferies on Tuesday, December 8. Jefferies maintained the shares of TXMD in report on Monday, September 21 with “Buy” rating. The rating was maintained by Stifel Nicolaus on Tuesday, December 8 with “Buy”. Oppenheimer initiated the shares of TXMD in report on Tuesday, November 22 with “Outperform” rating.

Another recent and important TherapeuticsMD, Inc. (NASDAQ:TXMD) news was published by Businesswire.com which published an article titled: “TherapeuticsMD Announces Investor and Analyst Day on June 4” on May 16, 2018.

Investors sentiment decreased to 1.62 in Q4 2017. Its down 0.11, from 1.73 in 2017Q3. It dropped, as 17 investors sold TXMD shares while 25 reduced holdings. 22 funds opened positions while 46 raised stakes. 159.91 million shares or 1.31% less from 162.04 million shares in 2017Q3 were reported. Td Asset reported 0% of its portfolio in TherapeuticsMD, Inc. (NASDAQ:TXMD). Bnp Paribas Arbitrage Sa has 35,061 shares for 0% of their portfolio. 100,109 were reported by Redmond Asset Mngmt Ltd Liability. Moreover, Goldman Sachs Group Inc Inc has 0% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD). Gilder Gagnon Howe And Company Ltd Liability holds 246,969 shares. Group One Trading LP has 0.01% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD) for 161,933 shares. Wells Fargo & Mn holds 0% in TherapeuticsMD, Inc. (NASDAQ:TXMD) or 193,443 shares. American Intl Gru has 0% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD) for 111,592 shares. Institute For Wealth Mgmt Ltd Liability Co reported 13,180 shares. Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 7,336 shares. Impact Limited Liability Company invested in 0.52% or 200,707 shares. Amalgamated Bankshares reported 0% stake. State Of Wisconsin Investment Board owns 113,000 shares. Susquehanna Gp Llp owns 502,684 shares. 3.32 million are owned by Voya Invest Mngmt Ltd Liability Corp.

TherapeuticsMD, Inc. (NASDAQ:TXMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>